Predicted to enable receptor ligand activity. Predicted to be involved in macrophage chemotaxis; phagocytosis; and superoxide anion generation. Predicted to act upstream of or within regulation of membrane potential and regulation of sensory perception of pain. Predicted to be located in membrane. Predicted to be active in extracellular space; glutamatergic synapse; and synaptic vesicle membrane. Orthologous to human TAFA4 (TAFA chemokine like family member 4); INTERACTS WITH 1-naphthyl isothiocyanate; 3-chloropropane-1,2-diol; 6-propyl-2-thiouracil.
chemokine-like protein TAFA-4; Fam19a4; family with sequence similarity 19 (chemokine (C-C motif)-like), member A4; family with sequence similarity 19 member A4, C-C motif chemokine like; family with sequence similarity 19, member A4; LOC689043; similar to TAFA4 protein
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ...
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ...
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ...
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ...
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...